Gene · 2931
Papers2,889
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,889
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Myeloid GSK3α Deficiency Reduces Lesional Inflammation and Neovascularization during Atherosclerotic Progression. | Int J Mol Sci | 2024 | 39456687 | PubTator, text mining | PubMed |
| Proteomics-based network pharmacology and molecular docking reveal the potential mechanisms of 5,6,7,4'-tetramethoxyflavone against HeLa cancer cells. | Heliyon | 2024 | 39449708 | PubTator, text mining | PubMed |
| Mass spectrometry-based multi-omics analysis reveals distinct molecular features in early and advanced stages of hepatocellular carcinoma. | Heliyon | 2024 | 39381095 | PubTator, text mining | PubMed |
| Animal models of haploinsufficiency revealed the isoform-specific role of GSK-3 in HFD-induced obesity and glucose intolerance. | Am J Physiol Cell Physiol | 2024 | 39344416 | PubTator, text mining | PubMed |
| Altered hepatic metabolic landscape and insulin sensitivity in response to pulmonary tuberculosis. | PLoS Pathog | 2024 | 39331683 | PubTator, text mining | PubMed |
| DVL/GSK3/ISL1 pathway signaling: unraveling the mechanism of SIRT3 in neurogenesis and AD therapy. | Stem Cell Res Ther | 2024 | 39267160 | PubTator, text mining | PubMed |
| A Novel 3-Benzyloxychromone From Celastrus orbiculatus Thunb. Exhibits Anticancer Effects on Non-Small Cell Lung Cancer Cells via GSK-3β-Dependent c-Jun/ATF2 Pathway. | Cell Biochem Funct | 2024 | 39215681 | PubTator, text mining | PubMed |
| Targeting Gsk3a reverses immune evasion to enhance immunotherapy in hepatocellular carcinoma. | J Immunother Cancer | 2024 | 39174053 | PubTator, text mining | PubMed |
| Benzimidazole-oxindole hybrids: A novel class of selective dual CDK2 and GSK-3β inhibitors of potent anticancer activity. | Arch Pharm (Weinheim) | 2024 | 39041665 | PubTator, text mining | PubMed |
| [Recent advances in protein precipitation-based methods for drug-target screening]. | Se Pu | 2024 | 38966970 | PubTator, text mining | PubMed |
| Evaluation of antitumor potential of an anti-glypican-1 monoclonal antibody in preclinical lung cancer models reveals a distinct mechanism of action. | Explor Target Antitumor Ther | 2024 | 38966167 | PubTator, text mining | PubMed |
| GSK3: A potential target and pending issues for treatment of Alzheimer's disease. | CNS Neurosci Ther | 2024 | 38946682 | PubTator, text mining | PubMed |
| Golgi dispersal in cancer stem cells promotes chemoresistance of colorectal cancer via the Golgi stress response. | Cell Death Dis | 2024 | 38879509 | PubTator, text mining | PubMed |
| Synthesis of novel hybrids of 1,2,3-triazoles-hydrazone: targeting cholinesterases and Alzheimer's related genes. | Future Med Chem | 2024 | 38864182 | PubTator, text mining | PubMed |
| GSK-3α-BNIP3 axis promotes mitophagy in human cardiomyocytes under hypoxia. | Free Radic Biol Med | 2024 | 38815772 | PubTator, text mining | PubMed |
| Natural compound screening predicts novel GSK-3 isoform-specific inhibitors. | Biochimie | 2024 | 38723940 | PubTator, text mining | PubMed |
| Discovery of Potent Multikinase Type-II Inhibitors Targeting CDK5 in the DFG-out Inactive State with Promising Potential against Glioblastoma. | J Med Chem | 2024 | 38686637 | PubTator, text mining | PubMed |
| Sex differences in neuronal oscillatory activity and memory in the methylazoxymethanol acetate model of schizophrenia. | Schizophr Res | 2024 | 38643726 | PubTator, text mining | PubMed |
| Germ cell-specific gene 2 accelerates cell cycle in epithelial ovarian cancer by inhibiting GSK3α-p27 cascade. | J Mol Histol | 2024 | 38613588 | PubTator, text mining | PubMed |
| CCDC28A deficiency causes sperm head defects, reduced sperm motility and male infertility in mice. | Cell Mol Life Sci | 2024 | 38597936 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2931/papers?page=4